In an interview with Consultant360, Paul B. Rosenberg, MD, discussed his team’s research on using dronabinol, a legal form of synthetic THC, to treat agitation in patients with Alzheimer disease. What...
Researchers report on the first safety and efficacy of mosunetuzumab, a CD20xCD3 T-cell engaging bispecific antibody, for patients with relapsed/refractory Mantle cell lymphoma. This study was presented at...
Researchers analyzed data from a nationwide cohort to evaluate the effectiveness of covalent Bruton tyrosine kinase inhibitors, used either as monotherapy or in combination with anti-CD20 monoclonal...
Researchers set out to determine the prevalence of pickleball-related fractures examined in United States emergency departments from 2002 to 2022, as well the demographics associated with those fractures....
Researchers evaluated the association between phosphodiesterase type 5 inhibitor initiation compared with nonuse and the risk of developing AD in men with erectile dysfunction.
The FDA approved irinotecan liposome with oxaliplatin, fluorouracil, and leucovorin as a first-line regimen for the management of patients with metastatic pancreatic adenocarcinoma.
The American Academy of Dermatology updated its 2016 guidelines for the management of acne vulgaris. The updated guidelines include 18 evidence-based recommendations and five good practice statements.
The CDC reported more than 200,000 cases of syphilis in 2022, a 17% increase compared with the previous year. In response, the CDC provided new recommendations for testing syphilis in the laboratory.
Researchers aimed to describe the most common symptoms of long COVID and the progression of symptoms over time. They presented their findings at IDWeek 2023 in Boston, Massachusetts.
In a population-based, cross-sectional study, researchers examined US women aged 20 to 49 years who were diagnosed with primary invasive breast cancer from 2000 through 2019.
